Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

"Faces" of the day:

Katharina Jandl

Nina Höller

Nariae Baik-Schneditz

Ellen Heitzer

Marianne Brodmann

Ewald Kolesnik

Bernhard Schwaberger

Maximilian Seles

Gabor Toth-Gayor

Lukas Peter Mileder

Niels Hammer

Christian Josef Hill

Christian Viertler

Philipp Klaritsch

Daniel Scherr

Harald Köfeler

Gerhard Pichler

Roland Malli

Michael Fuchsjäger

Gernot Plank

Peter Fickert

Richard Zigeuner

Peter Holzer

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Finkenstedt, A; Auer, C; Glodny, B; Posch, U; Steitzer, H; Lanzer, G; Pratschke, J; Biebl, M; Steurer, M; Graziadei, I; Vogel, W; Zoller, H.
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
Clin Gastroenterol Hepatol. 2013; 11(12):1667-1672 Doi: 10.1016/j.cgh.2013.06.025
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Lanzer Gerhard

Posch Ursula

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

The G-allele in position rs738409 of patatin-like phospholipase domain-containing protein 3 (PNPLA3) is associated with an increased hepatic concentration of triglyceride and is a risk factor for advanced liver disease. We investigated the association of donor and recipient risk alleles with the development of graft steatosis after liver transplantation. PNPLA3 genotypes were determined in 237 transplant recipients and in 255 organ donors. Macrovesicular steatosis was assessed by unenhanced computed tomography 5 years after liver transplantation in 95 patients and correlated with donor and recipient PNPLA3 genotype. The risk allele was significantly more frequent in transplant recipients than in donors (42% vs 28%; P < .001). A prevalence of graft steatosis of 30% or greater significantly increased from 11.6% at 1 year after liver transplantation to 32.6% at 5 years after transplantation. Five years after liver transplantation, steatosis was present in 63.2% of patients homozygous for the rs738409-G allele, in 31.4% of heterozygous recipients, and in 12.0% of rs738409-CC recipients (P = .002). Donor genotypes were not associated with the development of graft steatosis. In multivariate regression analysis, recipients who carried rs738409-GG had a 13.7-fold higher risk of graft steatosis than recipients who carried rs738409-CC (P = .022), independent of recipient age, weight gain after liver transplantation, or the underlying disease. Liver transplant recipients who carry rs738409-G in PNPLA3 are at increased risk for hepatic triglyceride accumulation, independent of the graft PNPLA3 genotype. Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Find related publications in this database (using NLM MeSH Indexing)

Adult -

Aged -

Fatty Liver - genetics

Female -

Genotype -

Genotyping Techniques -

Humans -

Lipase - genetics

Liver - pathology

Liver Transplantation -

Male -

Membrane Proteins - genetics

Middle Aged -

Polymorphism, Single Nucleotide -

Retrospective Studies -

Risk Factors -

Tomography, X-Ray Computed -

Transplantation -

Find related publications in this database (Keywords)

Genetics

Nonalcoholic Fatty Liver Disease

Alcoholic Liver Disease

Variant

© Med Uni Graz • Imprint